Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TESARO Inc (NASDAQ:TSRO)

43.81
Delayed Data
As of May 27
 +0.48 / +1.11%
Today’s Change
29.51
Today|||52-Week Range
66.95
-16.27%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$2.0B

Company Description

TESARO, Inc. engages in the research and development of biopharmaceutical products. It focuses on oncology-based therapeutics and consists of the following portfolio: Rolapitant IV and Niraparib. The company was founded by Leon Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA.

Contact Information

TESARO, Inc.
1000 Winter Street
Waltham Massachusetts 02451
P:(339) 970-0900
Investor Relations:
(781) 325-1116

Employees

Shareholders

Mutual fund holders59.65%
Individual stakeholders42.56%
Other institutional32.97%

Top Executives

Leon O. MoulderChief Executive Officer & Director
Mary Lynne HedleyPresident, Chief Operating Officer & Director
Timothy R. PearsonChief Financial Officer & Executive Vice President
Jeffrey H. HankeChief Scientific Officer & Executive VP
Martin H. HuberChief Medical Officer & Senior Vice President